News & Perspective

Nov 04, 2010

Nov 04, 2010

Grants for small biotechs include infectious-disease projects

(CIDRAP News) – Federal officials announced yesterday that $1 billion worth of grants and tax credits will be awarded to thousands of small biotechnology companies to support the development of new medical therapies, including a number of products for infectious diseases.

Aug 30, 2010

Aug 30, 2010

HHS funds development of drug for plague, tularemia

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.

Aug 11, 2010

Aug 11, 2010

Healthcare-related MRSA decreases, but reasons unclear

(CIDRAP News) – A new large-scale study of methicillin-resistant Staphylococcus aureus (MRSA) infections shows that infection rates have dropped in hospitalized people and those recently exposed to healthcare settings, but experts aren't sure what factors are driving the decline.

Jun 16, 2010

Jun 16, 2010

Report says fight against drug resistance must go global

(CIDRAP News) – Efforts to battle major diseases in the developing world are leading to increased drug resistance, creating a need for a coordinated global campaign to maintain the effectiveness of antimicrobial drugs, a US nonprofit policy research group said in a report released this week.

May 17, 2010

May 17, 2010

Staph patterns in hospitalized kids drive treatment changes

(CIDRAP News) – A study designed to explore management of Staphylococcus aureus of hospitalized children found that methicillin-resistant (MRSA) infections rose tenfold over the 10-year study period, leading to dramatic changes in antibiotic prescribing patterns.

Apr 23, 2010

Apr 23, 2010

H1N1 LESSONS LEARNED Pandemic underscored influenza's unpredictability

Editor's Note: This is the first of a series of articles reviewing the world's experience with pandemic H1N1 influenza and what we've learned in the past year. Look for further installments in the days to come.

(CIDRAP News) – A year's experience with the 2009 H1N1 influenza virus has underscored the endless unpredictability of flu.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»